Dublin, Dec. 18, 2017 -- The "Lower Urinary Tract Symptoms Forecast in 12 Major Markets 2018-2028" report has been added to Research and Markets' offering.
This report provides the current prevalent population for Lower Urinary Tract Symptoms across 12 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Russia, Japan, China, India, Brazil) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Lower urinary tract symptoms (LUTS) are a standardised group of symptoms related to problems with the voiding, storage and post-micturition of urine, occurring in both males and females. Differences between sexes regarding the type and frequency of symptoms have been observed. LUTS are a major burden for middle-aged and elderly people, and have a significant influence on health-related quality of life in that group.
Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Lower Urinary Tract Symptoms have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main co-morbidities for Crohn's disease include:
- Overweight and obesity
- Arterial hypertension
- Diabetes mellitus
- Coronary artery disease
- Metabolic syndrome (obesity, hypertension, diabetes and dyslipidaemia)
- Urinary tract infections
- Neurological disorders
- Erectile dysfunction in men
Key Topics Covered:
- Introduction
- Cause of the Disease
- Risk Factors & Prevention
- Diagnosis of the Disease
- Variation by Geography/Ethnicity
- Disease Prognosis & Clinical Course
- Key Comorbid Conditions / Features Associated With the Disease
- Methodology for Quantification of Patient Numbers
- Additional Data Available on Request
- Top-Line Prevalence for Lower Urinary Tract Symptoms
- Features of Lower Urinary Tract Symptoms Patients
- Male Patients With Lower Urinary Tract Symptoms
- Female Patients With Lower Urinary Tract Symptoms
- Comorbid Conditions of Luts Patients
- Abbreviations Used in the Report
- Other Publications
- Online Patient-Based Databases
- Patient-Based Offering
- Online Pricing Data & Platforms
- References
- Appendix
For more information about this report visit https://www.researchandmarkets.com/research/r78bmt/global_lower?w=12
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Urological Disorders Drugs


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Washington Post Publisher Will Lewis Steps Down After Layoffs
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Samsung Electronics Shares Jump on HBM4 Mass Production Report
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Amazon Explores AI Content Marketplace With Media Publishers
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 



